Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Gilead jumps into a competitive Protein degradation field, signs a USD 45 M Nurix dealGilead Sciences is turning to Nurix Therapeutics for enhancing cancer pipeline. Gilead is ready to pay US...
Osteoporosis is a bone disease that makes bones weak and brittle. Osteoporosis, as the word says itself “porous bones”. As we age, bone density decreases and even mild stress or a light fall can c...
Gene Therapy is a way to introduce a normal working gene in the place of a mutated one which might result in some kinds of abnormalities. Gene Therapy is a novel way to express novel proteins, and...
The Chinese government is going on the offensive against scientists who dupe journals by creating fraudulent reviews of submitted papers. A coalition of agencies led by the science ministry announc...
Non-melanoma skin cancer is a group of cancers of the skin and is broadly classified into Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). It has the greatest prevalence in the United ...
Jason Sheltzer, a cancer biologist at Cold Spring Harbor Laboratory in New York, was on the hunt for genes involved in tumour growth. He and his colleagues planned to disable the MELK gene using th...
There might be many treatment options for a cancer patients, but each one has its limitations. Also, a physician has a challenge in determining the best treatment method for an individual. However,...
There has been a shocking revelation in a report published in Science Translational Medicine by Bengt Westermark, a tumour biologist at Uppsala, who reports that a cell line widely used to study br...
Cancer has gripped the world in its clutches, and the grip hasn’t loosened for the past 3 decades. Research into cancer prognosis and treatment has many hurdles, and these hurdles keep on increasin...
Human Immunodeficiency Virus or HIV is a species of Lentivirus (genus of retrovirus) th...
Progress is driven by innovation. When it comes to developing novel medications and the...
The HIV-1 treatment market for naïve and experienced patients is evolving consistently....
The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...
Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
